VIC 2022 Mid-Year Update Executive Summary

The first half of the year has been exciting for VIC and our portfolio companies, including new pre-clinical and clinical milestones reached, products released to market, recent funding, and more Click Here to download...

Inside CTTC at Vanderbilt University with Assistant Director, Physical Sciences Ashok Choudhury

Tell us about your background in technology transfer and commercialization. What experiences led you to this role? During my role as a researcher at a national laboratory, I worked at a DOE “User Center” where I had the...

VIC Tech Announces New Class of Fellows

The VIC Tech investment model is unique; it sources promising life science innovation directly from universities across the nation, allocating funding to form startup companies and advance these technologies to exit via...

Cellia Science Announces Dr. Wilbur Lam as Chief Medical Officer

Dr. Lam brings clinical and technical expertise to hematology analyzer development at Cellia Science Fayetteville, AR - Cellia Science, Inc., announced today the appointment of Wilbur Lam, MD, PhD, as Chief Medical...

CardioWise Joins the Lucem Health Innovation Collaborative as a Founding Member

Bringing AI/ML to the Front Lines of Healthcare Fayetteville, AR - CardioWise® and Lucem Health™ announced that CardioWise has become a founding member of the Lucem Health Innovation Collaborative, a partner program...

Challenges and Solutions for University Technology Commercialization (Part 1)

The honest truth? Deciding which early-stage technologies will be successful is really hard. This is even more the case when you add the challenges faced in a university setting. Although I’m currently on the investment...

VIC Tech Grows Its Medical Advisory Board

VIC Tech is pleased to announce the addition of five new members to its Medical Advisory Board to help guide VIC with additional domain expertise across a variety of life science disciplines. MAB members support VIC’s...

From the Corner Office: Filtravate

“We can’t change the whole world, but let’s try to work to make our corner of it better.”  COVID-19 didn't happen in a vacuum, as our globe has several comorbidities occurring in tandem; global warming, clean water...

Cellia Science Formed to Develop and Commercialization Point-of-Care Hematology Analyzers

New company to advance blood cell analysis using label-free deep-UV imaging Fayetteville, AR - VIC Technology Venture Development, LLC (VIC) announced today the formation of Cellia Science, Inc., to develop and...

VIC Fellows Spotlight: Cristhiaan Ochoa, MD, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...


VIC 2021 Annual Report Executive Summary
Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Inside UCSF Innovation Ventures with Executive Director, Anthony Francis
Protecting Early Investors in Capital-Intensive Life Science Companies
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
VIC Fellows Spotlight: Kelly Mabry, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission